Acute rejection · lung transplant recipients
Tacrolimus showed no clear difference in acute rejection The number of patients who experienced at least one… compared with cyclosporin (low certainty).
1 finding from 1 review
Bronchiolitis obliterans syndrome · lung transplant recipients
Tacrolimus probably leads to lower bronchiolitis obliterans syndrome The number of patients diagnosed… compared with cyclosporin (moderate certainty).
1 finding from 1 review
Infection The number of overall infections per 100 patient days · lung transplant recipients
1 finding from 1 review
Treatment withdrawal · lung transplant recipients
Tacrolimus may leads to lower treatment withdrawal the number of patients stopping the assigned… compared with cyclosporin (low certainty).
1 finding from 1 review
Hypertension · lung transplant recipients
Tacrolimus may leads to lower arterial hypertension compared with cyclosporin (low certainty).
1 finding from 1 review
Diabetes · lung transplant recipients
Tacrolimus may leads to higher diabetes mellitus compared with cyclosporin (low certainty).
1 finding from 1 review
Wound dehiscence · people with surgical incisions
Octylcyanoacrylate showed no clear difference in wound dehiscence compared with butylcyanoacrylate (low certainty).
1 finding from 1 review
Wound infection · people with surgical incisions
Octylcyanoacrylate showed no clear difference in wound infection compared with butylcyanoacrylate (low certainty).
1 finding from 1 review
Quality of life, measured by CRQ (dyspnoea, fatigue, emotional function, and mastery subscales) · patients with chronic obstructive pulmonary disease
1 finding from 1 review
All‐cause serious adverse events 60 weeks (end of study) · patients with chronic obstructive pulmonary disease
It is very uncertain whether macrolide+tetracycline changes all‐cause serious adverse events 60 weeks (end of study) compared with macrolide (very low certainty).
1 finding from 1 review
Change in baseline trough FEV1 · patients with chronic obstructive pulmonary disease
1 finding from 1 review
All‐cause mortality 60 weeks (end of study) · patients with chronic obstructive pulmonary disease
It is very uncertain whether macrolide+tetracycline changes all‐cause mortality 60 weeks (end of study) compared with macrolide (very low certainty).
1 finding from 1 review
Number of people experiencing one or more exacerbations, Drug resistance/microbial sensitivity (as reported by trialists), including emergence of atypical bacteria, Number of participants colonised with Pseudomonas aeruginosa · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality Total of deaths and the end of · acute bleeding gastric varices in people with portal hypertension
It is very uncertain whether cyanoacrylate changes mortality Total of deaths and the end of compared with band ligation (very low certainty).
1 finding from 1 review
Mortality Total deaths at 30 days · acute bleeding gastric varices in people with portal hypertension
It is very uncertain whether cyanoacrylate changes mortality Total deaths at 30 days compared with alcohol (very low certainty).
1 finding from 1 review
Failure of intervention · acute bleeding gastric varices in people with portal hypertension
It is very uncertain whether cyanoacrylate changes failure of intervention compared with alcohol (very low certainty).
1 finding from 1 review
Complications (fever) Presence of fever · acute bleeding gastric varices in people with portal hypertension
It is very uncertain whether cyanoacrylate changes complications (fever) Presence of fever compared with alcohol (very low certainty).
1 finding from 1 review
Re‐bleeding Re‐bleeding after intervention · acute bleeding gastric varices in people with portal hypertension
It is very uncertain whether cyanoacrylate changes re‐bleeding Re‐bleeding after intervention compared with alcohol (very low certainty).
1 finding from 1 review
Control of bleeding Success in control the active variceal bleeding · acute bleeding gastric varices in people with portal hypertension
It is very uncertain whether cyanoacrylate changes control of bleeding Success in controlling the active variceal… compared with alcohol (very low certainty).
1 finding from 1 review
Failure of intervention Continuous variceal bleeding after intervention · acute bleeding gastric varices in people with portal hypertension
It is very uncertain whether cyanoacrylate changes failure of intervention Continuous variceal bleeding after… compared with band ligation (very low certainty).
1 finding from 1 review